Objective
to compare 5-year clinical outcomes among patients treated with ultrathin strut bioresorbable polymer sirolimus-eluting stents (BP-SES) and thin strut durable polymer everolimus-eluting stents (DP-EES)
Study
prospective, multicentre, randomised clinical trial
Population
adults with ischaemic heart disease undergoing planned PCI in de-novo, native coronary lesions
Endpoints
target lesion failure at 5 years
Conclusion
at 5 years, TLF was similar among patients treated with BP SES versus DP EES
Kandzari et al. JACC Cardiovasc Interv. 2022;15:1852-60
